Mr. Wijenthiran is a distinguished academic, having earned his BSc (Hons.) in Bioinformatics in 2006 and an MSc in Biotechnology in 2011 from the prestigious University of Malaya. Throughout his academic journey, his focus has been on pioneering research in the therapeutic potential of dental-derived Mesenchymal Stem Cells (MSCs) for treating neurodegenerative diseases.
His exemplary contributions have been widely recognized, highlighted by his publications in esteemed international scientific journals. Particularly notable is his role as one of the key inventors behind an optimized technique for the isolation of Wharton’s Jelly MSC, a groundbreaking advancement poised for therapeutic applications within a GMP facility.